Showing results (41-50 of 311) with videos related to

Sort By:
Pageof 32
Medical Mycology Case Reports|November 10, 2025
Combined intracavitary, systemic antifungal and surgical treatment of Chronic Pulmonary Aspergillosis: experience from an immunocompromised patientAnne Haglund, Jelena Stankovic, Thomas Decker Christensen, et al.
Haematologica|October 13, 2005
Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cellsSusanne Hipp, Ingo Ringshausen, Madlene Oelsner, et al.
Interactive Cardiovascular and Thoracic Surgery|February 11, 2021
What is the optimal level of suction on digital chest drainage devices following pulmonary lobectomy?Marlene Fromm Sørensen, Bo Laksáfoss Holbek, René Horsleben Petersen, et al.
Annals of Hematology|August 16, 2008
A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLLThomas Decker, Michael Sandherr, Katharina Goetze, et al.
Experimental Hematology|March 20, 2003
Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathwaysChristian Bogner, Folker Schneller, Susanne Hipp, et al.
Metallomics : Integrated Biometal Science|April 15, 2015
Contrasting regulation of macrophage iron homeostasis in response to infection with Listeria monocytogenes depending on localization of bacteriaDavid Haschka, Manfred Nairz, Egon Demetz, et al.
Ugeskrift for Laeger|August 6, 2021
[Volume-reducing treatment of pulmonary emphysema]Jesper Dichmann de Vos, Michael Perch, Thomas Decker Christensen, et al.
Ugeskrift for Laeger|October 5, 2002
[Self-management of oral anticoagulant therapy in children with congenital heart defects]Thomas Decker Christensen, Jørn Attermann, Vibeke Elisabeth Hjortdal, et al.
Blood|February 7, 2002
Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotidesThomas Decker, Susanne Hipp, Robert J Kreitman, et al.
Urologia Internationalis|November 15, 2019
A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ)Martin Schostak, Patrick de Geeter, Thomas Decker, et al.
Pageof 32